Decreased Susceptibility to Polymyxin B during Treatment for Carbapenem-Resistant Klebsiella pneumoniae Infection

被引：83

作者：

Lee, Jooyun ^{[1
]}

Patel, Gopi ^{[1
]}

Huprikar, Shirish ^{[1
]}

Calfee, David P. ^{[1
]}

Jenkins, Stephen G. ^{[2
]}

机构：

[1] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY 10029 USA

[2] Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2009年 / 47卷 / 05期

关键词：

NEGATIVE BACTERIA; BETA-LACTAMASE; COLISTIN; TIGECYCLINE; COMBINATION;

D O I：

10.1128/JCM.02466-08

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：1611 / 1612

页数：2

共 11 条

[1] Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients:: first report of a multiclonal cluster [J].

Antoniadou, Anastasia ;

Kontopidou, Flora ;

Poulakou, Garifalia ;

Koratzanis, Evangelos ;

Galani, Irene ;

Papadomichelakis, Evangelos ;

Kopterides, Petros ;

Souli, Maria ;

Armaganidis, Apostolos ;

Giamarellou, Helen .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) :786-790

[2] Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing enterobactefiaceae:: Report from the SENTRY antimicrobial surveillance program [J].

Castanheira, Mariana ;

Sader, Helio S. ;

Deshpande, Lalitagauri M. ;

Fritsche, Thomas R. ;

Jones, Ronald N. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :570-573

[3] Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections [J].

Falagas, ME ;

Kasiakou, SK .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1333-1341

[4] Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies [J].

Kelesidis, Theodoros ;

Karageorgopoulos, Drosos E. ;

Kelesidis, Iosif ;

Falagas, Matthew E. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) :895-904

[5] Evaluation of colistin as an agent against multi-resistant in Gram-negative bacteria [J].

Li, J ;

Nation, RL ;

Milne, RW ;

Turnidge, JD ;

Coulthard, K .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (01) :11-25

[6] Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study [J].

Matthaiou, Dimitrios K. ;

Michalopoulos, Argyris ;

Rafailidis, Petros I. ;

Karageorgopoulos, Drosos E. ;

Papaioannou, Vassiliki ;

Ntani, Georgia ;

Samonis, George ;

Falagas, Mafthew E. .

CRITICAL CARE MEDICINE, 2008, 36 (03) :807-811

[7] In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline-amikacin synergy [J].

Moland, Ellen S. ;

Craft, David W. ;

Hong, Seong-geun ;

Kim, Soo-young ;

Hachmeister, Lucas ;

Sayed, Shimon D. ;

Thomson, Kenneth S. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (08) :2940-2942

[8] In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis [J].

Petersen, PJ ;

Labthavikul, P ;

Jones, CH ;

Bradford, PA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (03) :573-576

[9] Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies [J].

Petrosillo, N. ;

Ioannidou, E. ;

Falagas, M. E. .

CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (09) :816-827

[10] Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae [J].

Yigit, H ;

Queenan, AM ;

Anderson, GJ ;

Domenech-Sanchez, A ;

Biddle, JW ;

Steward, CD ;

Alberti, S ;

Bush, K ;

Tenover, FC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1151-1161

← 1 2 →